These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30734632)

  • 1. Association between
    Kamio H; Uchiyama T; Kanno H; Onoe Y; Saito K; Kameoka S; Kamio T; Okamoto T
    Pharmacogenomics; 2019 Apr; 20(5):353-365. PubMed ID: 30734632
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetics and a phase I study of tegafur-uracil enterogranules in cancer patients].
    Kamiya O; Hoshino A; Ohara K; Nagata K; Kojima T; Sugihara T; Yamada M; Suzuki M; Kimura K; Fujii S
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2565-72. PubMed ID: 6418079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of co-administration of uracil and tegafur (UFT) in hepatocellular carcinoma. Tokyo Liver Cancer Chemotherapy Study Group.
    Jpn J Clin Oncol; 1985 Sep; 15(3):559-62. PubMed ID: 2997511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double blind comparative study of tegafur (FT) and UFT (a combination of Tegafur and uracil) in advanced breast cancer.
    Tashiro H; Nomura Y; Ohsaki A
    Jpn J Clin Oncol; 1994 Aug; 24(4):212-7. PubMed ID: 8072200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of pulmonary metastasis from renal cell carcinoma with complete response to interferon-alpha and tegafur/uracil (UFT) but possibly UFT-induced liver dysfunction and leukoencephalopathy-like symptoms].
    Suzuki K; Nukui A; Kobayashi M; Sugaya Y; Muraishi O; Morita T; Tokue A
    Hinyokika Kiyo; 1999 Sep; 45(9):621-4. PubMed ID: 10540708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug-induced liver injury associated with uracil/tegafur + folinate therapy].
    Kawasaki A; Mimatsu K; Kuboi Y; Kano H; Oida T; Amano S
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1901-3. PubMed ID: 19920397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized phase II study of anastrozole plus tegafur-uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC).
    Nakayama T; Sagara Y; Takashima T; Matsunami N; Masuda N; Miyoshi Y; Taguchi T; Aono T; Ito T; Kagimura T; Noguchi S
    Cancer Chemother Pharmacol; 2018 Apr; 81(4):755-762. PubMed ID: 29468454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe chronic active hepatitis induced by UFTR containing tegafur and uracil.
    Kobayashi F; Ikeda T; Sakamoto N; Kurosaki M; Tozuka S; Sakamoto S; Fukuma T; Marumo F; Sato C
    Dig Dis Sci; 1995 Nov; 40(11):2434-7. PubMed ID: 7587827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
    Watanabe T; Sano M; Takashima S; Kitaya T; Tokuda Y; Yoshimoto M; Kohno N; Nakagami K; Iwata H; Shimozuma K; Sonoo H; Tsuda H; Sakamoto G; Ohashi Y
    J Clin Oncol; 2009 Mar; 27(9):1368-74. PubMed ID: 19204202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safety and compliance with UFT (tegafur and uracil) alone and in combination with hormone therapy in patients with breast cancer].
    Taguchi T; Noguchi S
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1465-74. PubMed ID: 19755814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative, randomized trial of UFT and 5-fluorouracil in combination with cyclophosphamide and doxorubicin in the treatment of advanced breast cancer patients at The Philippines General Hospital.
    Villalon AH; De Guzman LM; Samson MC; Guancia AA; Fernando GY; Romana IB
    Oncology; 1997; 54 Suppl 1():2-6. PubMed ID: 8978577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).
    Oki E; Murata A; Yoshida K; Maeda K; Ikejiri K; Munemoto Y; Sasaki K; Matsuda C; Kotake M; Suenaga T; Matsuda H; Emi Y; Kakeji Y; Baba H; Hamada C; Saji S; Maehara Y
    Ann Oncol; 2016 Jul; 27(7):1266-72. PubMed ID: 27056996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I/II study of oral uracil/tegafur (UFT), leucovorin and irinotecan in patients with advanced colorectal cancer.
    Mackay HJ; Hill M; Twelves C; Glasspool R; Price T; Campbell S; Massey A; Macham MA; Uzzel M; Bailey SM; Martin C; Cunningham D
    Ann Oncol; 2003 Aug; 14(8):1264-9. PubMed ID: 12881390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scleroderma-like reaction induced by uracil-tegafur (UFT), a second-generation anticancer agent.
    Kono T; Ishii M; Negoro N; Taniguchi S
    J Am Acad Dermatol; 2000 Mar; 42(3):519-20. PubMed ID: 10688731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur-uracil versus surgery alone in stage II colon cancer: SACURA trial.
    Matsuda C; Ishiguro M; Teramukai S; Kajiwara Y; Fujii S; Kinugasa Y; Nakamoto Y; Kotake M; Sakamoto Y; Kurachi K; Maeda A; Komori K; Tomita N; Shimada Y; Takahashi K; Kotake K; Watanabe M; Mochizuki H; Nakagawa Y; Sugihara K;
    Eur J Cancer; 2018 Jun; 96():54-63. PubMed ID: 29677641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uracil-tegafur in gastric carcinoma: a comprehensive review.
    Takiuchi H; Ajani JA
    J Clin Oncol; 1998 Aug; 16(8):2877-85. PubMed ID: 9704742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose oral tegafur-uracil maintenance therapy in patients with uterine cervical cancer.
    Sakaguchi I; Motohara T; Saito F; Takaishi K; Fukumatsu Y; Tohya T; Shibata S; Mimori H; Tashiro H; Katabuchi H
    J Gynecol Oncol; 2015 Jul; 26(3):193-200. PubMed ID: 25686399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of preoperative chemoradiation with tegafur-uracil plus leucovorin for locally advanced rectal cancer with pharmacogenetic analysis.
    Kim SY; Baek JY; Oh JH; Park SC; Sohn DK; Kim MJ; Chang HJ; Kong SY; Kim DY
    Radiat Oncol; 2017 Mar; 12(1):62. PubMed ID: 28347333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of five studies on tegafur plus uracil (UFT) as post-operative adjuvant chemotherapy for breast cancer.
    Kasumi F; Yoshimoto M; Uchino J; Abe R; Nomura Y; Sugimachi K; Nakazato H; Abe O
    Oncology; 2003; 64(2):146-53. PubMed ID: 12566912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian variations in the pharmacokinetics of the oral anticancer agent tegafur-uracil (UFT) and its metabolites in rats.
    Kobuchi S; Ito Y; Takamatsu D; Sakaeda T
    Eur J Pharm Sci; 2018 Oct; 123():452-458. PubMed ID: 30077713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.